Hosa Pharmacology

5.0(1)
studied byStudied by 10 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/264

flashcard set

Earn XP

Description and Tags

Good Luck

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

265 Terms

1
New cards

FDA (food and drug administration)

-approve new drugs to be sold in the US

2
New cards

-process New Drug Applications (NDA)

3
New cards

-regulate package inserts

4
New cards

-regulate drug advertising

5
New cards

-issue recalls

6
New cards

-federal agency

7
New cards

DEA (Drug Enforcement Agency)

-federal agency

8
New cards

-enforce the CSA ( controlled substances act)

9
New cards

-track controlled substances manufactured and sold

10
New cards

-investigates all violations involving controlled substances

11
New cards

-set the DEA Sch. Definitions

12
New cards

-issue DEA numbers

13
New cards

BOP (Board of Pharmacy) (each state)

-regulate licensing of pharmacists

14
New cards

-regulate licensing of pharmacy technicians

15
New cards

-set state laws/ requirements

16
New cards

-outline the operating guidelines in the pharmacy

17
New cards

-investigate violations of the operating guidelines

18
New cards

-determine state regulated controlled substances

19
New cards

-state agency

20
New cards

Joint Commission on Accreditation of Healthcare Organizations

-watches over healthcare organizations

21
New cards

-third party auditors/ regulators for insurance providers

22
New cards

DEA Schedule I

-no accepted medical use

23
New cards

-extremely high potential for abuse

24
New cards

-high potential for psychological and physical dependency

25
New cards

-ex. weed, heroin, mdma

26
New cards

DEA Schedule II

-does have medical use

27
New cards

-high potential for abuse

28
New cards

-relative potential for psychological and physical dependency

29
New cards

-ex. oxycodone, codeine, retalin

30
New cards

-no refillls allowed

31
New cards

-cannot be "called in" or transmitted electronically unless it is an absolute emergency

32
New cards

DEA Schedule III

-does have medical use

33
New cards

-moderate abuse potential exits

34
New cards

-ex. vicodin and tylenol w/ codeine

35
New cards

DEA Schedule IV

-abuse potential exists

36
New cards

-ex. ambien, darvocet, lorazepam

37
New cards

DEA Schedule V

-lowest abuse potential

38
New cards

-ex. cough medicine w/ codeine or anti-diarrheas

39
New cards

DEA Form 222

-must be used whenever Sch I or II drugs are bought, sold or transferred between pharmacies or qualified distributors

40
New cards

DEA number verification

-add the 1st, 3rd, and 5th digits

41
New cards

-add the 2nd, 4th, and 6th digits. double it

42
New cards

-add the two totals together. the second digit is the check digit

43
New cards

-preceded by two letters: first letter represents the type of practice or institution the DEA number is issued to, the second letter represents the first letter of the practitioner's last name

44
New cards

sig

-tells pharm techs how to dispense it

45
New cards

-also printed on the prescription it is dispensed in but translated into regular words for the patient

46
New cards

Expiration dates: DEA Sch II

no expiration

47
New cards

Expiration dates: DEA Sch III thru V

6 months

48
New cards

Expiration dates: Legend Drugs

12 months

49
New cards

Refills: DEA Schedule II

no refills allowed

50
New cards

Refills: DEA Schedule III thru V

-up to 5, but only 5 times

51
New cards

-if a patient can only afford 50 at a time then they will only get 250 total

52
New cards

Refills: Legend Drugs

up to 12 months worth

53
New cards

DEA Controlled Drug Prescriptions must contain at least:

-date of prescription issue

54
New cards

-patient's name and address

55
New cards

-practitioner's name, address, and phone number

56
New cards

-drug name

57
New cards

-drug strength

58
New cards

-dosage form and instructions

59
New cards

-exact quantity prescribed

60
New cards

-complete directions for use

61
New cards

-number of refills authorized

62
New cards

-a valid DEA number

63
New cards

Schedule II drug prescription:

-must be manually signed by the practitioner. no exceptions

64
New cards

-may not be faxed or called in, except for a valid emergency

65
New cards

-may not have any refills

66
New cards

FDA Recall Class I

would be used in a case where there is a probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

67
New cards

FDA Recall Class II

would be used in a case where use of a violative product may cause temporary health problems and the probability of serious adverse health consequence is remote

68
New cards

FDA Recall Class III

may be used in a situation in which use of a violative product is not likely to cause adverse health consequence, but has violated some FDA regulation

69
New cards

FDA Market Withdrawal

appropriate when a product has a minor violation that would be not subject to FDA legal action. the manufacture must remove the product from distribution markets or correct the violation. "a product removed from the market due to tampering, without evidence of manufacturing or distribution problems, would be a market withdrawal"

70
New cards

FDA Medical Device Safety Alert

used only for medical apparatus equipment. this is when a medical device may present an unreasonable risk of substantial harm. in some cases, these situation also are considered recalls.

71
New cards

NDA Process: Initial Development: Pre Clinical

pre-clinical (animal) testing

72
New cards

NDA Process: Initial Development: Investigational New Drug Review (IND)

-review of pre-clinical trial results

73
New cards

-determination of safety to use on humans

74
New cards

-authorization to ship across state lines

75
New cards

NDA Process: New Drug Clinical Trials: Phase I

-involves 25-100 volunteers

76
New cards

-safety tolerated dosage determined

77
New cards

-identification of major side effects

78
New cards

-emphasis on safety and maximum tolerated dosages

79
New cards

NDA Process: New Drug Clinical Trials: Phase II

-involves 100-300 volunteers

80
New cards

-emphasis on the drug effect against what it's designed to treat

81
New cards

-effets compared with similar patients receiving different treatments

82
New cards

NDA Process: New Drug Clinical Trials: Phase III

-involves 300-3000 volunteers

83
New cards

-emphasis on the drugs overall effect

84
New cards

-effects compared with patients taking placebos

85
New cards

-study of different population and different dosages

86
New cards

-testing the drug in combination with other drugs

87
New cards

-final phase before presenting to FDA for approval

88
New cards

NDA Process: New Drug Post Approval Trials: Phase IV

-ongoing/post approval trials

89
New cards

-health-care professionals to report any adverse findings

90
New cards

-lasts eternally, as long as the drug is on the market

91
New cards

NDA Process Time

-can usually take 12-15 years

92
New cards

-patent only last 20 years from the time the application for patent was filled

93
New cards

Federal Food and Drug Act of 1906

-known as the Pure Food and Drug Act

94
New cards

-provided authority for federal inspection of meat products and prohibited the sale of adulterated foods

95
New cards

-required that "secret elixirs" containing ingredients like: cocaine, heroin, morphine and alcohol which were available at most stores as miracle cure-alls be labeled with correct information about their ingredients as well as suggested dosages

96
New cards

-replaced by the Federal Food, Drug and Cosmetic Act of 1938

97
New cards

Narcotic Tax Act of 1914

-known as the Harrison Narcotic Act

98
New cards

-provided authority for the IRS to collect taxes on Opiates thru tax stamps

99
New cards

-required that any entity which produced, distributed, dispensed or sold opiates be registered with the IRS

100
New cards

-emphasis was on attempting to control the massive flow of opiates in order to protect the public from rising addiction